VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 142 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $545,616 | -32.2% | 126,300 | +3.4% | 0.00% | -100.0% |
| Q2 2023 | $805,298 | -2.9% | 122,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $829,738 | -17.8% | 122,200 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,009,474 | -23.8% | 136,600 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $1,324,000 | -7.8% | 134,000 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $1,436,000 | -3.6% | 131,700 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,490,000 | -22.7% | 131,700 | +7.2% | 0.00% | 0.0% |
| Q4 2021 | $1,927,000 | -8.5% | 122,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,105,000 | -19.1% | 122,800 | +1.5% | 0.00% | -50.0% |
| Q2 2021 | $2,603,000 | +38.6% | 121,000 | -3.2% | 0.00% | +100.0% |
| Q1 2021 | $1,878,000 | +15.6% | 125,000 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $1,624,000 | +36.0% | 123,600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,194,000 | -12.9% | 123,600 | +3.2% | 0.00% | 0.0% |
| Q2 2020 | $1,371,000 | +42.1% | 119,800 | +28.7% | 0.00% | 0.0% |
| Q1 2020 | $965,000 | -35.9% | 93,100 | +1.4% | 0.00% | -50.0% |
| Q4 2019 | $1,506,000 | +26.7% | 91,800 | +2.6% | 0.00% | +100.0% |
| Q3 2019 | $1,189,000 | -4.2% | 89,500 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $1,241,000 | -29.4% | 88,100 | -7.7% | 0.00% | -50.0% |
| Q1 2019 | $1,757,000 | -27.4% | 95,500 | +3.1% | 0.00% | -33.3% |
| Q4 2018 | $2,420,000 | +18.5% | 92,600 | +4.0% | 0.00% | +50.0% |
| Q3 2018 | $2,043,000 | +20.5% | 89,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,695,000 | +13.0% | 89,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,500,000 | +42.0% | 89,000 | +28.1% | 0.00% | +100.0% |
| Q4 2017 | $1,056,000 | -15.1% | 69,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,244,000 | +9.8% | 69,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,133,000 | +27.6% | 69,500 | +9.6% | 0.00% | 0.0% |
| Q1 2017 | $888,000 | -12.2% | 63,400 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $1,011,000 | -4.2% | 63,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,055,000 | +48.8% | 63,400 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $709,000 | +31.8% | 63,400 | -4.9% | 0.00% | 0.0% |
| Q1 2016 | $538,000 | +7.8% | 66,700 | +24.4% | 0.00% | 0.0% |
| Q4 2015 | $499,000 | -17.5% | 53,600 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $605,000 | +7.8% | 53,600 | +21.3% | 0.00% | +100.0% |
| Q2 2015 | $561,000 | +43.1% | 44,200 | +4.7% | 0.00% | 0.0% |
| Q1 2015 | $392,000 | -35.1% | 42,200 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $604,000 | +53.3% | 42,200 | +11.1% | 0.00% | 0.0% |
| Q3 2014 | $394,000 | -35.9% | 38,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $615,000 | – | 38,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |